Duloxetine hydrochloride (LAUNXP)

盐酸度洛西汀 (LAUNXP)

Report date: 2024/08/21 18:28:45

Base Information

Drug NameDuloxetine hydrochloride (LAUNXP)
Drug Alias NameLXP5268LXP-5268LXPB-5268
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsNorepinephrine transporter inhibitors
TargetsSerotonin transporterNorepinephrine transporter
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesLAUNXP Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLAUNXP Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A